Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained Symptoms: A Quasi-experimental Study

Not Applicable

Not yet recruiting

• Conditions: Medically Unexplained Symptoms

• Registration Number: NCT07007013
• Lead Sponsor: Consorci Sanitari de l'Alt Penedès i Garraf

Brief Summary

This study aims to study the effectiveness of the intervention for medically unexplained symptoms(MUS) in terms of changes in emotional well-being before and after the intervention (humor therapy)

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-05
• Study First Submitted: 2025-05-28
• Study First Submitted QC: 2025-05-28
• Last Update Submitted: 2025-05-28
• Study First Posted: 2025-06-05
• Last Update Posted: 2025-06-05
• Study Start: 2025-09
• Primary Completion: 2026-09
• Study Completion: 2026-09-30

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

Participants may be included in the trial if they meet all of the following inclusion criteria:

Men and women over 18 years of age.

Diagnosed with the condition under study (see Section 2: Definitions).

Expected to undergo follow-up for their condition at the study center.

Ability to participate in the required assessments.

Legal capacity to provide informed consent.

Signed informed consent for inclusion in the study, either by the participant or their legal representative.

Exclusion Criteria

Participants will be excluded if they meet any of the following exclusion criteria:

Participants diagnosed with any of the following conditions:

Severe mental health disorder, as determined by the investigator

Cognitive impairment of any etiology, as recorded in the medical history

Treatment for the condition under study using community-based resources prescribed in Primary Care within the past 6 months.

Cognitive or affective disorders that limit the ability to comply with study procedures.

Participation in another study involving an experimental intervention during the period of the present trial and/or requiring visit schedules that are incompatible with this trial.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
emotional well-being	From baseline to 6 months after ending the intervention	Emotional well-being will be measured before-after intervention through the Warwick-Edinburgh Mental Well-being Scale (WEMWBS)

Trial Locations

Locations (1)

CAPI Baix A Mar (CSAPG); 🇪🇸 Vilanova i la Geltrú, Barcelona, Spain